http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-PI0413595-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1bde28565d28f037e78bf4a67776ee24
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2602-08
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P7-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P41-004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C35-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C29-143
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C17-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D241-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C35-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C29-143
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P7-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C17-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C25-22
filingDate 2004-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fafb5c3a0a47ae2a6d4788af68566612
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07a691965dbbf09af93f80a97787406e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb747e93f50958571337396522895180
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba023162cefca69eaf54b8ea726093cc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d94f4814ef02d5431a14c211071834e2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_854814d362788f9f1f531b3cec4e8c36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1838f890ce116628719fc63115094ff7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dedd195925d4f310c285ffab2f0a62af
publicationDate 2006-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-PI0413595-A
titleOfInvention succinate salt or malonate salt, crystalline hydrogen malonate salt, pharmaceutical composition, use of a salt, method of making a compound, and
abstract "SUCCINATE SALT OR MALONATE SALT, CRYSTALLINE MALONATE HYDROGEN SALT, PHARMACEUTICAL COMPOSITION, USE OF A SALT, METHOD OF MAKING A COMPOUND, AND COMPOUND". Hydrogen succinate or 4 - ((1R, 3S) -6-chloro-3-phenylindan-1-yl) -1,2,2-trimethylpiperazine malonate hydrogen, pharmaceutical compositions containing these salts and their clinical use, including for the treatment of schizophrenia and other psychotic disorders. Methods for the preparation of 4 - ((1R, 3S) -6-chloro-3-phenylindan-1-yl) -1,2,2-trimethylpiperazine and clinical uses thereof are also described.
priorityDate 2003-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410072001
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419592315
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3693574
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3748644
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11465618
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411880055

Total number of triples: 50.